These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23630300)

  • 21. Islet of Langerhans transplantation for the treatment of type 1 diabetes.
    Bucher P; Mathe Z; Bosco D; Andres A; Bühler LH; Morel P; Berney T
    Swiss Surg; 2003; 9(5):242-6. PubMed ID: 14601328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant.
    Iwanaga Y; Matsumoto S; Okitsu T; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Fukuda K; Tsukiyama K; Tanaka K
    Ann N Y Acad Sci; 2006 Oct; 1079():335-9. PubMed ID: 17130575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute insulin responses to glucose and arginine as predictors of beta-cell secretory capacity in human islet transplantation.
    Rickels MR; Naji A; Teff KL
    Transplantation; 2007 Nov; 84(10):1357-60. PubMed ID: 18049122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.
    Turgeon NA; Avila JG; Cano JA; Hutchinson JJ; Badell IR; Page AJ; Adams AB; Sears MH; Bowen PH; Kirk AD; Pearson TC; Larsen CP
    Am J Transplant; 2010 Sep; 10(9):2082-91. PubMed ID: 20883542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
    Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
    Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
    Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
    Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year follow-up after clinical islet transplantation.
    Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
    Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin independence of unstable diabetic patient after single living donor islet transplantation.
    Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K
    Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.
    Graham ML; Bellin MD; Papas KK; Hering BJ; Schuurman HJ
    Xenotransplantation; 2011; 18(6):328-42. PubMed ID: 22168140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellence of suito index for assessing clinical outcome of islet transplantation.
    Matsumoto S; Noguchi H; Takita M; Shimoda M; Tamura Y; Olsen G; Chujo D; Naziruddin B; Onaca N; Levy MF
    Transplant Proc; 2010; 42(6):2062-4. PubMed ID: 20692408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Super-high-dose islet transplantation is associated with high SUITO index and prolonged insulin independence: a case report.
    Matsumoto S; Noguchi H; Takita M; Shimoda M; Tamura Y; Olsen G; Naziruddin B; Onaca N; Levy MF
    Transplant Proc; 2010; 42(6):2156-8. PubMed ID: 20692432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful islet transplantation from the pancreata of non-heart-beating donors.
    Kenmochi T; Maruyama M; Saigo K; Akutsu N; Iwashita C; Otsuki K; Ito T; Suzuki A; Miyazaki M; Saito T
    Transplant Proc; 2008 Oct; 40(8):2568-70. PubMed ID: 18929803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report.
    Yang HK; Ham DS; Park HS; Rhee M; You YH; Kim MJ; Kim JW; Lee SH; Hong TH; Choi BG; Cho JH; Yoon KH
    J Korean Med Sci; 2015 Jul; 30(7):991-4. PubMed ID: 26130966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade.
    Blau JE; Abegg MR; Flegel WA; Zhao X; Harlan DM; Rother KI
    Am J Transplant; 2015 Nov; 15(11):2995-3001. PubMed ID: 26184712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
    Posselt AM; Bellin MD; Tavakol M; Szot GL; Frassetto LA; Masharani U; Kerlan RK; Fong L; Vincenti FG; Hering BJ; Bluestone JA; Stock PG
    Am J Transplant; 2010 Aug; 10(8):1870-80. PubMed ID: 20659093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet transplantation in type I diabetes mellitus.
    Jamiolkowski RM; Guo LY; Li YR; Shaffer SM; Naji A
    Yale J Biol Med; 2012 Mar; 85(1):37-43. PubMed ID: 22461742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.
    Liu EH; Digon BJ; Hirshberg B; Chang R; Wood BJ; Neeman Z; Kam A; Wesley RA; Polly SM; Hofmann RM; Rother KI; Harlan DM
    Diabetologia; 2009 Jul; 52(7):1369-80. PubMed ID: 19418039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.